-
Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Marco Sebastiani,Gemma Lepri,Claudia Iannone,Emanuele Bozzalla Cassione,Giuliana Guggino,Andrea Lo Monaco,Roberta Foti,Marco Fornaro,Maria Sole Chimenti,Angelo Fassio,Simona Truglia,Francesca Cozzini,Antonio Carletto,Alessandro Giollo,Addolorata Corrado,Chiara Bazzani,Serena Guiducci,Ennio Favalli,Serena Bugatti,Florenzo Iannone,Roberto Caporali,Andreina Manfredi
OBJECTIVE Some concerns remain about the safety of nintedanib in patients with interstitial lung disease (ILD) related to rheumatoid arthritis (RA-ILD), such as in presence of comorbidities or in combination with biologic, targeted synthetic and/or conventional synthetic disease modifying antirheumatic drugs (DMARDs). In this multicentre study, we retrospectively evaluated the safety of nintedanib
-
IgG4-Related Arterial Disease: An Unusual Case of Aortitis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Martin Soubrier,Eric Hachulla
-
Rheumatoid Arthritis Treatment Has Changed Dramatically Over the Past 3 Decades, but Has the Disease Itself Changed? J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Carol A Hitchon,Hani S El-Gabalawy
-
Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Tiphaine Goulenok,Arthur Mageau,Chrystelle François,Claire Dossier,Eric Hachulla,Thomas Papo,Karim Sacré
-
What's in a Name: The Value of Defining Core Competencies for Extended Role Practitioners in Arthritis Care. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Amanda Steiman,Katie Lundon,Laura Passalent,Leslie Soever,Deborah M Levy,Christopher Nielsen,Rachel Shupak
-
Effective Use of Apremilast in Refractory Arthritis Associated With Cystic Fibrosis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Angelo Nigro
-
High-Sensitivity Cardiac Troponin T as a Marker to Improve Cardiovascular Disease Risk Assessment Among Patients With Rheumatoid Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Gang Wang,Zhichun Liu
-
Use of Single-Arm Observational Data for Causal Inference: The Case of GLA:D for Hip and Knee Osteoarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Daniel L Riddle,Ian A Harris,Robin Christensen
-
Impact of Age on Rheumatic Immune-related Adverse Events: Experience from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO). J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Jenny Li,Marie Hudson,Carrie Ye,Janet Roberts,Aurore Fifi-Mah,May Y Choi,Sabrina Hoa,C Thomas Appleton,Janet Pope,Nancy Maltez,Lourdes Gonzalez Arreola,Anthony Obrzut,Shahin Jamal,
OBJECTIVE Immune checkpoint inhibitors (ICI) have revolutionized cancer outcomes but are limited by immunerelated adverse events (irAE), including rheumatic irAEs (Rh-irAE). Aging is associated with increased inflammation, referred to as "inflamm-aging". In this study, we explore the impact of age on severity, frequency, and treatment of Rh-irAEs. METHODS Adults with new Rh-irAEs after ICI exposure
-
-
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Miguel Ángel González-Gay,Santos Castañeda,Iván Ferraz-Amaro
-
Cancer incidence and outcome for patients with Rheumatoid Arthritis: a long-term population study in Western Australia. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Johannes Nossent,Helen I Keen,David B Preen,Charles A Inderjeeth
OBJECTIVE To compare malignancy incidence and impact between hospitalized patients with Rheumatoid Arthritis (RA) and controls. METHODS Population-level observational study of patients with RA identified (ICD-9CM 714, ICD10-AM M05-M06) in the Hospital Morbidity Data Collection (HDMC) in Western Australia (WA) between 1985 and 2015 and non-exposed hospitalised controls matched on gender, age and year
-
Improving Gout Care in a Canadian Academic Medical Center Through a Multidisciplinary Nurse-Led Protocol. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Thomas Audet,Marie-Aude Picard-Turcot,Julie Robindaine,Nathalie Carrier,Pierre Dagenais
OBJECTIVE Following Health Canada's knowledge translation framework, we report the results of a clinical audit from 2012 to 2015 followed by a multidisciplinary, nurse-led gout care protocol with a treat-to-target (T2T) strategy implemented in April 2018. METHODS A clinical audit with chart reviewing was completed for adults with gout and urate-lowering therapy (ULT) indication at the Centre Hospitalier
-
Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic population of Reunion Island (France): a retrospective multicentric study. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-13 Mathurin Maillet,Babacar Sakhir Tounkara,Damien Vagner,Kelly Bagny,Sébastien Duquenne,Céline Lartigau-Roussin,Anne Kolbe,Yves Lauret,Andry Randrianjohany,Serge Laureau,Nicole Denat,Aude Alquier,Nathalie Sultan-Bichat,Antoine Bertolotti,Loïc Raffray
OBJECTIVE Little data is available about the epidemiology of cutaneous lupus erythematosus (CLE) in South hemisphere and in multiethnic populations. We describe the prevalence and incidence of isolated CLE in the multiethnic population of Reunion Island (France), with its clinical characteristics. METHODS The study was performed in the public hospitals and private dermatology practices of Reunion Island
-
Exome sequencing of Singapore Chinese anti-citrullinated-protein-antibody-positive rheumatoid arthritis patients. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Khai Pang Leong,Mei Yun Yong,Ee Tzun Koh,Peter Pak Moon Cheung,Manjari Lahiri,Chin Teck Ng,Chia Mun Woo,Liuh Ling Goh,Sandy Hong Hong Lim,Preeti Dhanasekaran,Grace Yee May Cheah,Justina Wei Lyn Tan,Wenchao Hu,Mei Ling Chong,Vikrant Kumar,Sonia Davila,
OBJECTIVE More than 130 susceptibility loci for rheumatoid arthritis (RA) have been identified with genome-wide association studies (GWAS). To investigate the genetic predisposition of Chinese anti-cyclic-citrullinated-peptides-antibody-positive RA, we carried out an exome sequencing study. METHODS Patients were recruited from three major public hospitals in Singapore, Tan Tock Seng Hospital (TTSH)
-
The Early Course of Radiographic Progression in Axial Spondyloarthritis: Have We Missed Something? J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Jürgen Braun
-
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Peter Stoustrup,Christian J Kellenberger,Christian Høst,Annelise Küseler,Thomas K Pedersen,Troels Herlin,Mia Glerup
OBJECTIVE This prospective study investigates the efficacy of biologics in combination with methotrexate or leflunomide on juvenile idiopathic arthritis (JIA)- related temporomandibular joint (TMJ) arthritis measured by magnetic resonance imaging (MRI)-based inflammation score and deformity score. METHODS A prospective single center observational cohort study of 18 consecutive patients were performed
-
Wearable in Systemic Sclerosis: A Pilot Study of the Apollo Wearable Demonstrates Improvement in Fatigue, Raynaud Phenomenon and Quality-of-Life in Patients with Systemic Sclerosis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Krista Hammaker,Haomin Hu,Maureen Laffoon,Leigh A Freno,Robert Lafyatis,Yongseok Park,Robyn T Domsic
OBJECTIVE In systemic sclerosis (SSc) patients, fatigue is the highest ranked symptom affecting quality of life (QoL), followed by Raynaud phenomenon (RP). We report results from a pilot study (NCT04854850) of the Apollo wearable device in SSc patients. METHODS Twenty-five adult participants with SSc, moderate fatigue and RP were enrolled. Participants completed a 4-week intervention, during which
-
Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Masataka Kuwana,Naoko Wakasugi,Tetsuji Hashida,Satoshi Uno,Takafumi Suda
-
Evaluating and Refining Strategies for Rheumatoid Arthritis Prevention in First Nations Communities. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Sijia Liu,Ruwei Hu
-
Patient Profiles in Randomized Controlled Trials Versus a Real-World Study in Psoriatic Arthritis: Scoping Review and Metaanalysis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Gelsomina Alle,Clementina Lopez-Medina,Stefan Siebert,Frédéric Lavie,Wim Noel,Josef S Smolen,Laure Gossec
OBJECTIVE Patients with psoriatic arthritis (PsA) in randomized controlled trials (RCTs) may not reflect patients with PsA in clinical practice. Our objective was to perform a metaanalysis comparing the characteristics of patients with PsA in RCTs of biologic disease-modifying antirheumatic drugs (bDMARDs) to patient profiles in a real-world study. METHODS Data sources included (1) a scoping literature
-
Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Fumika N Nagase,Sho Fukui,Naoho Takizawa,Toshihiro Yamaguchi,Nobuhiro Oda,Hajime Inokuchi,Takanori Ito,Mitsuru Watanabe,Masei Suda,Yoichiro Haji,Yasuhiro Suyama,Ryo Rokutanda,Masahiro Minoda,Atsushi Nomura,Eishi Uechi,Hiromichi Tamaki
OBJECTIVE Tocilizumab (TCZ) is effective for giant cell arteritis (GCA). However, little is known regarding treatment modification and clinical outcomes after unfavorable events such as GCA relapses or TCZ discontinuation due to adverse events (AEs). METHODS This multicenter retrospective study included patients with GCA who initiated TCZ from 2008 to 2021 at 5 Japanese hospitals. GCA relapses and
-
Broadening the Landscape for Treatment Recommendations in the Management of Axial Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Wilson Bautista-Molano
-
Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Laura Ross,Stephanie Bond,Jessica A Day
-
Association of Past Smoking Status With Gout in Māori People in Aotearoa New Zealand. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Niamh C Fanning,John F Pearson,Nicola Dalbeth,Huti Watson,Tony R Merriman,Lisa K Stamp
OBJECTIVE Evidence for an association of smoking with gout is conflicting. We assessed associations of current and past smoking with gout in an Aotearoa New Zealand (NZ) population. METHODS Multivariable logistic regression analysis was performed on cross-sectional data from participants of NZ Māori (from 2 studies: Genetics of Gout in Aotearoa [GGA] study of 293 participants with gout and 431 without;
-
Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic Diseases. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Vijaya Prasanna Parimi,Vinod Ravindran
-
The evaluation of myocarditis in patients with Still's disease; clinical findings from the multicentre international AIDA Network Still's Disease Registry. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Piero Ruscitti,Ilenia Di Cola,Antonio Vitale,Valeria Caggiano,Pierpaolo Palumbo,Ernesto Di Cesare,Jiram Torres-Ruiz,Guillermo Arturo Guaracha-Basañez,Eduardo Martín-Nares,Francesco Ciccia,Daniela Iacono,Flavia Riccio,Maria Cristina Maggio,Samar Tharwat,Soad Hashad,Donato Rigante,Augusta Ortolan,Henrique A Mayrink Giardini,Isabele Parente de Brito Antonelli,Rafael Alves Cordeiro,Roberto Giacomelli,Luca
OBJECTIVE To evaluate the cardiac involvement in patients with Still's disease with a focus on myocarditis included in the multicenter AIDA (AutoInflammatory Disease Alliance) network Still's disease registry. To exploit the predictive factors for myocarditis in deriving a clinical risk patient profile for this severe manifestation. METHODS A multicenter observational study was built up assessing consecutive
-
Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis) Commencing Late in Life. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Mark C Hwang,Karim Doughem,MinJae Lee,Lianne S Gensler,Mariko L Ishimori,Michael M Ward,Matthew A Brown,Amirali Tahanan,Michael H Weisman,Mohammad H Rahbar,John D Reveille
-
Large Language Models in Rheumatologic Diagnosis: A Multimodal Performance Analysis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Mahmud Omar,Reem Agbareia,Eyal Klang,Mohammad E Naffaa
-
A Stratification Approach Based on Salivary Gland Ultrasonography for Assessing Secretory Function in Sjögren Disease. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-15 Wenke Huang,Shaoyun Hao,Zhiming Ouyang,Liqin Peng,Xinghuan Chen,Wenjing Yang,Wenjing Zhong,Junsheng Chen,Lie Dai,Yingqian Mo
OBJECTIVE Our aim was to develop an ultrasonographic scoring model for staging hypofunction of salivary glands (SGs) in patients with Sjögren disease (SjD). METHODS The assessment of SG secretory hypofunction was conducted by measuring whole salivary flows. B-mode ultrasonography was performed bilaterally on the parotid and submandibular glands to quantitatively evaluate the gland score and Outcome
-
Symptom Severity and Glucocorticoid Dosing in Patients With Polymyalgia Rheumatica and Obesity. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Marco A Cimmino,Cynthia S Crowson,Bhaskar Dasgupta,Michael Schirmer,Christian Dejaco,Carlo Salvarani,Eric L Matteson,Dario Camellino
OBJECTIVE Polymyalgia rheumatica (PMR) is an inflammatory disorder of the elderly characterized by girdle pain and stiffness. Obesity has an influence on disease activity and outcome in rheumatic diseases like osteoarthritis and rheumatoid arthritis. We aimed to investigate the relationship between high BMI and the severity and outcome of PMR, which is incompletely understood. METHODS In a post hoc
-
The Lived Experiences of Older Adults With Systemic Lupus Erythematosus: Patient Perspectives. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Sarah B Lieber,Sarah R Young,Yvonne Shea,Sarah P Gottesman,Robyn Lipschultz,Dongmei Sun,M Carrington Reid,Lisa A Mandl,Iris Navarro-Millán
OBJECTIVE Little is known about perceptions of aging among individuals with systemic lupus erythematosus (SLE). Gaining this knowledge could help to identify targets for future behavioral interventions aimed at successful aging with SLE. This qualitative study sought to elicit the lived experiences and essence of aging from older adults with SLE. METHODS We conducted semistructured interviews with
-
Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Kaveh Ardalan,Lisa G Rider
The development and validation of measures of disease activity, damage, and health-related quality of life (HRQOL) over the past 30 years has been fundamental in advancing research and care for patients with adult and juvenile idiopathic inflammatory myopathies (IIMs).1 These efforts have resulted in the development of core set measures of disease activity and damage for myositis, and the American
-
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Renato Ferrandiz-Espadin,Gabriela Rabasa,Sarah Gasman,Brooke McGinley,Rachael Stovall,S Reza Jafarzadeh,Jean W Liew,Maureen Dubreuil
OBJECTIVE Radiographic axial spondyloarthritis (r-axSpA) has a 7-year average diagnostic delay. Although the effects of sex or gender on time to diagnosis have been evaluated, the role of social determinants of health remains understudied. We assessed whether time from initial clinical documentation of r-axSpA symptoms to r-axSpA diagnosis (diagnostic delay) varies based on sex, race, ethnicity, and/or
-
Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients With Systemic Lupus Erythematosus. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Yiran Jiang,Alí A Duarte-García,Michael S Putman,David J Gazeley
OBJECTIVE Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection that may affect patients with systemic lupus erythematosus (SLE). The objective of this project was to describe the incidence of PJP among patients with SLE. METHODS A retrospective cohort analysis of the TriNetX database was conducted. Included patients had ≥ 2 International Classification of Diseases, 9th or 10th revision
-
Infected Tumoral Calcinosis Associated With Rheumatoid Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Eri Sugawara,Keita Ninagawa,Kazuaki Katsumata
Tumoral calcinosis (TC) is a syndrome of unknown etiology characterized by calcium salt deposition in soft tissues.1 A case of infected TC with rheumatoid arthritis (RA) is described.
-
Hydrocephalus-Related Dementia in Paget Disease of the Skull. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 João Daniel Ferreira Carvalho,José Carlos Romeu
Paget disease of bone (PDB) is a chronic skeletal disorder caused by abnormal bone remodeling. Although neurological complications are uncommon, they may arise in advanced cases, particularly with skull involvement.
-
Mucosa-Associated Lymphoid Tissue Lymphoma as a Rare Mimicker of Relapsing Polychondritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Norihisa Tada,Nao Oguro,Nobuyuki Yajima
Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade B cell extranodal lymphoma characterized by clonal marginal zone lymphocyte proliferation. We report a case of MALT lymphoma with a relapsing polychondritis (RP)-like phenotype, manifesting as rapidly progressive tracheal stenosis requiring tracheotomy.
-
Changes at Presentation in Patients With Early Rheumatoid Arthritis: A 24-Year Study of the Early Undifferentiated Polyarthritis (EUPA) Cohort. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Nathalie Carrier,Sophie Roux,Ariel Masetto,Artur J de Brum-Fernandes,Patrick Liang,Meryem Maoui,Gilles Boire
OBJECTIVE To analyze changes in baseline characteristics of patients with very early rheumatoid arthritis (RA) over 24 years in the Early Undifferentiated Polyarthritis (EUPA) cohort. METHODS Consecutive patients with recent-onset polyarthritis fulfilling RA classification criteria recruited in EUPA were assessed at baseline. Three successive periods were defined: (1) prior to the general availability
-
When to Schedule Your Next COVID-19 Vaccine. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Hinpetch Daungsupawong,Viroj Wiwanitkit
-
Prologue: Spondyloarthritis Unmet Research Needs Conference IV. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Robert A Colbert,Ellen Carroll,Maureen Dubreuil,Lianne S Gensler,Nigil Haroon,Richard Howard,Alexis R Ogdie,Cassie Shafer,Pamela F Weiss,Kristine A Kuhn
The Spondylitis Association of America (SAA) and the National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) convened a conference on the campus of the National Institutes of Health (NIH) on September 28 and 29, 2023, to identify unmet needs in spondyloarthritis (SpA) research. The conference featured presentations by experts in areas of disease endotypes, pain, innovative imaging
-
Are There Disease Endotypes in Axial Spondyloarthritis and How Would We Define Them? J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Kevin D Deane,Laura T Donlin,Christopher T Ritchlin,Kristine A Kuhn
Is axial spondyloarthritis (axSpA) one disease or does it comprise multiple types? If the latter, how do we define those types-through clinical or imaging features, HLA-B27 status, or by other immunologic features? Data comparing disease outcomes for individuals with nonradiographic vs radiographic axSpA, or for male vs female patients, demonstrate distinctions. So then, how should we define endotypes
-
Enhancing Equity in Clinical Research: A Multifaceted Proposal for Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Maureen Dubreuil,Elizabeth D Ferucci,Hani El-Gabalawy,Sarfaraz Hasni,Edith M Williams
Clinical research advances medical knowledge and improves healthcare outcomes. However, disparities in research participation hinder progress. The Unmet Research Needs in Spondyloarthritis Conference IV highlighted critical insights and strategies to enhance equity in clinical research. Talks focused on engaging underrepresented communities and addressing disparities in rheumatic diseases, particularly
-
Unmet Needs in Spondyloarthritis: Pathogenesis, Clinical Trial Design, and Nonpharmacologic Therapy. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Laura C Coates,Georg Schett,Chenchen Wang,Pamela F Weiss
A program focused on pathogenesis, clinical trial design, and nonpharmacologic mind-body therapy for spondyloarthritis (SpA) was presented at the Spondylitis Association of America Unmet Needs Conference IV. SpA pathogenesis is incompletely understood but involves a complex set of drivers, including genetics, biomechanical stress, and microbial factors. Affected tissues may include axial and peripheral
-
Unmet Needs in Spondyloarthritis: Understanding and Managing Chronic Pain. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Yvonne C Lee,Anne-Marie Malfait,Alexis R Ogdie
Among patients with axial spondyloarthritis (axSpA), persistent pain remains a critical unmet need. In this review, we discuss the prevalence of chronic pain and fibromyalgia in patients with axSpA and examine the existing knowledge on the pathophysiology of chronic pain in SpA, osteoarthritis, and rheumatoid arthritis. Finally, we discuss the specific unmet needs that must be addressed to improve
-
Unmet Needs in Spondyloarthritis: Imaging in Axial Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Lianne S Gensler,Lennart Jans,Sharmila Majumdar,Denis Poddubnyy
Imaging biomarkers in axial spondyloarthritis (axSpA) are currently the most specific biomarkers for the diagnosis of this condition. Despite advances in imaging, from plain radiographs-which detect only damage-to magnetic resonance imaging (MRI)-which identifies disease activity and structural change-there are still many challenges that remain. Imaging in sacroiliitis is characterized by active and
-
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Xuanyi Liu,Junmei Zhang,Hui Xu,Weiying Kuang,Jianghong Deng,Xiaohua Tan,Chao Li,Shipeng Li,Yuan Xue,Guoshuang Feng,Caifeng Li
OBJECTIVE Juvenile dermatomyositis (JDM) is a rare but chronic autoimmune disease with systemic nonsuppurative inflammation. Many studies have focused on the clinical characteristics and therapy of JDM. Whereas a few studies have reported the epidemiological characteristics and social burden of patients with JDM internationally, no study has been performed in China to date. METHODS This study was based
-
Infections in Vasculitis: Can We Create an Epidemic of Change? J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Gretchen Santana Cepero,John E McKinnon,Kathleen Maksimowicz-McKinnon
In the article entitled "Prevalence, Predictors, and Prognosis of Serious Infections in Takayasu Arteritis: A Cohort Study" by Misra and colleagues in this issue of The Journal of Rheumatology, the authors examine the incidence of serious infections in a Takayasu arteritis (TA) patient cohort; analyze associated demographic, clinical, angiographic, and treatment-related factors; and evaluate their
-
Effect of Online Training on the Reliability of Assessing Sacroiliac Joint Radiographs in Axial Spondyloarthritis: A Randomized, Controlled Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Anna E F Hadsbjerg,Mikkel Østergaard,Joel Paschke,Raphael Micheroli,Susanne J Pedersen,Adrian Ciurea,Michael J Nissen,Kristyna Bubova,Stephanie Wichuk,Manouk de Hooge,Simon Krabbe,Ashish J Mathew,Monika Gregová,Marie Wetterslev,Karel Gorican,Karlo Pintaric,Ziga Snoj,Burkhard Möller,Alexander Bernatschek,Maurice Donzallaz,Robert G Lambert,Walter P Maksymowych
OBJECTIVE Radiographic assessment of sacroiliac joints (SIJs) according to the modified New York (mNY) criteria is key in the classification of axial spondyloarthritis but has moderate interreader agreement. We aimed to investigate the improvements of the reliability in scoring SIJ radiographs after applying an online real-time iterative calibration (RETIC) module, in addition to a slideshow and video
-
Disability Related to the Upper Extremities in Early Rheumatoid Arthritis-Long-Term Course and Disease Variable Impact: A Cohort Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Maria Rydholm,Sofia Hagel,Lennart T H Jacobsson,Carl Turesson
OBJECTIVE To investigate the course of disability related to the upper extremities (UEs) in early rheumatoid arthritis (RA), and to assess correlations between such disability and clinical variables, including grip force. METHODS In an inception cohort of patients with early RA (diagnosed 1995-2005, N = 222, follow-up 10 yrs), disability of the UEs was assessed using a subscore of the Health Assessment
-
Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Rachel E Giblon,Sara J Achenbach,Elena Myasoedova,John M Davis,Vanessa L Kronzer,William V Bobo,Cynthia S Crowson
OBJECTIVE To investigate trends in depression and anxiety over 3 decades among individuals with rheumatoid arthritis (RA). METHODS Patients with incident RA (age ≥ 18 years, meeting 1987 American College of Rheumatology criteria between 1985 and 2014) were identified using the Rochester Epidemiology Project. Individuals with RA were matched 1:1 with non-RA comparators on age, sex, and calendar year
-
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Victoria Navarro-Compán,Martin Rudwaleit,Maureen Dubreuil,Marina Magrey,Helena Marzo-Ortega,Philip J Mease,Jessica A Walsh,Maxime Dougados,Christine de la Loge,Carmen Fleurinck,Ute Massow,Thomas Vaux,Vanessa Taieb,Atul Deodhar
OBJECTIVE To assess the effect of bimekizumab on pain, morning stiffness, and fatigue in patients with nonradiographic and radiographic axial spondyloarthritis (axSpA) in the phase III BE MOBILE studies (ClinicalTrials.gov: NCT03928704 and NCT03928743). METHODS Patients were randomized to bimekizumab 160 mg or placebo every 4 weeks; and all patients received bimekizumab from week 16. Patients reported
-
The Rheumatologist as the Agent of Change: Utility of Guidelines in the Management of Gout. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Puja P Khanna
The development and implementation of guidelines are intended to improve the quality of care by translating current evidence into clinical practice. However, the publication and dissemination of guidelines do not intuitively result in their use. Evidence indicates that structured implementation can improve guideline adherence.1.
-
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Sofia Exarchou,Daniela Di Giuseppe,Eva Klingberg,Valgerdur Sigurdardottir,Sara Wedrén,Ulf Lindström,Carl Turesson,Lennart T H Jacobsson,Johan Askling,Johan K Wallman
OBJECTIVE Prior incidence estimates of psoriatic arthritis (PsA) vary considerably. We aimed to assess the annual incidence of clinically diagnosed PsA among adults in Sweden in 2014-2016, overall and stratified by age/sex/education/geography, and to investigate potential time trends in incidence in 2006-2018. Use of disease-modifying antirheumatic drugs (DMARDs) during the 2 years after diagnosis
-
A Real-World Analysis of Weather Variation on Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Maxine Joly-Chevrier,Louis Coupal,Loïc Choquette Sauvageau,Mohammad Movahedi,Denis Choquette
OBJECTIVE Patients with inflammatory articular diseases, such as psoriatic arthritis (PsA), report weather changes in their symptoms. Our objective was to investigate the correlation between weather variation, disease activity (DA), and patient-reported outcomes (PROs) in patients with PsA. METHODS Hourly measurements of temperature, relative humidity, and pressure were obtained from 2015 to 2020 in
-
Fetal Atrial Flutter: A Potential Rare Phenotype of Maternal SSA/SSB Antibody-Associated Fetal Cardiac Disease. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Romeo Micu,Dan Boitor-Borza,Mihaela Cosmina Micu
Fetal atrial flutter (AF) is a reentrant tachyarrhythmia characterized by very fast, regular atrial and ventricular rates (400-500 bpm and 200-220 bpm, respectively). It occurs mainly in an anatomically normal heart and is usually treated with digoxin, which is often effective, with no further recurrence.1.
-
Gut Microbiomics of Sustained Knee Pain in Patients With Knee Osteoarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-12-01 Jingyi Huang,Ming Liu,Andrew Furey,Proton Rahman,Guangju Zhai
OBJECTIVE To examine whether gut microbes were associated with postsurgery-sustained knee pain in patients with knee osteoarthritis (OA) by a gut microbiomics approach. METHODS Patients receiving total knee replacement (TKR) because of primary knee OA were recruited. Sustained knee pain status at ≥ 1 year after TKR was defined by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
-
Stop Interfering! A Reflection on the Intrusive and Elusive Nature of Pain in Juvenile Idiopathic Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Tara R McGrath,Dax G Rumsey
The face of juvenile idiopathic arthritis (JIA) management has transformed over the last 30 years, with advancements that have dramatically improved outcomes and overall prognosis. Yet, despite contemporary advances, including biologic therapies, pain in patients with JIA remains common.1.
-
Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Romina Estefanía Nieto,Graciela S Alarcón,Laurent Arnaud,Guillermo Javier Pons-Estel
The article by Tani et al, "Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study,"1 evaluates the efficacy of anifrolumab (ANI) in patients with systemic lupus erythematosus (SLE) who failed to respond to other treatments, including biologics.There are many unmet needs in the treatment of SLE. Despite recent advances, remission and low disease activity (LDA) rates
-
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 David J Harris,Douglas H N White,Uri M Arad
OBJECTIVE Acute and chronic calcium pyrophosphate (CPP) crystal arthritis is characterized by the presence of synovial CPP crystals within a clinically inflamed joint. CPP crystals may be situated intracellularly or extracellularly; however, the clinical significance of their location remains understudied. The objective of this retrospective cohort study was to assess the relevance of the CPP crystal